Issue 2/2018
Content (24 Articles)
Localized targeted antiangiogenic drug delivery for glioblastoma
Gregory D. Arnone, Abhiraj D. Bhimani, Tania Aguilar, Ankit I. Mehta
Temporal stability of MGMT promoter methylation in glioblastoma patients undergoing STUPP protocol
C. J. O’Regan, H. Kearney, A. Beausang, M. A. Farrell, F. M. Brett, J. B. Cryan, T. E. Loftus, P. G. Buckley
Overexpression of aryl hydrocarbon receptor (AHR) signalling pathway in human meningioma
Noble Kumar Talari, Manas K. Panigrahi, Sailaja Madigubba, Prakash Babu Phanithi
Analysis of immunobiologic markers in primary and recurrent glioblastoma
Maryam Rahman, Jesse Kresak, Changlin Yang, Jianping Huang, Wesley Hiser, Paul Kubilis, Duane Mitchell
A combined diffusion tensor imaging and Ki-67 labeling index study for evaluating the extent of tumor infiltration using the F98 rat glioma model
Kai Wang, Tingting Ha, Xuzhu Chen, Shaowu Li, Lin Ai, Jun Ma, Jianping Dai
Immunophenotyping of pediatric brain tumors: correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response
Ashley S. Plant, Shohei Koyama, Claire Sinai, Isaac H. Solomon, Gabriel K. Griffin, Keith L. Ligon, Pratiti Bandopadhayay, Rebecca Betensky, Ryan Emerson, Glenn Dranoff, Mark W. Kieran, Jerome Ritz
Sex-dependent association of preoperative hematologic markers with glioma grade and progression
Wenshen Xu, Dengliang Wang, Xiaobin Zheng, Qishui Ou, Liming Huang
Recursive partitioning analysis is predictive of overall survival for patients undergoing spine stereotactic radiosurgery
Ehsan H. Balagamwala, Jacob A. Miller, Chandana A. Reddy, Lilyana Angelov, John H. Suh, Muhammad B. Tariq, Erin S. Murphy, Kailin Yang, Toufik Djemil, Anthony Magnelli, Alireza M. Mohammadi, Sherry Soeder, Samuel T. Chao
Discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis
Jaehag Jung, Seung Hoon Lee, Mira Park, Ji Hye Youn, Sang Hoon Shin, Ho Shin Gwak, Heon Yoo
Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma
Deborah R. Smith, Cheng-Chia Wu, Heva J. Saadatmand, Steven R. Isaacson, Simon K. Cheng, Michael B. Sisti, Jeffrey N. Bruce, Sameer A. Sheth, Andrew B. Lassman, Fabio M. Iwamoto, Shih-Hsiu Wang, Peter Canoll, Guy M. McKhann 2nd, Tony J. C. Wang
Normalization of ADC does not improve correlation with overall survival in patients with high-grade glioma (HGG)
Lei Qin, Angie Li, Jinrong Qu, Katherine Reinshagen, Xiang Li, Su-Chun Cheng, Annie Bryant, Geoffrey S. Young
The impact of a mind–body program on multiple dimensions of resiliency among geographically diverse patients with neurofibromatosis
Emily L. Zale, Catherine Pierre-Louis, Eric A. Macklin, Eric Riklin, Ana-Maria Vranceanu
Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
Pedro Góes, Bruno Fernandes Oliveira Santos, Fernando Seiji Suzuki, Débora Salles, João Noberto Stávale, Sérgio Cavalheiro, Manoel Antônio de Paiva Neto
PedsQL Neurofibromatosis Type 1 Module for children, adolescents and young adults: feasibility, reliability, and validity
Kavitha Nutakki, James W. Varni, Nancy L. Swigonski
Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas
Katherine B. Peters, Eric S. Lipp, Elizabeth Miller, James E. Herndon II, Frances McSherry, Annick Desjardins, David A. Reardon, Henry S. Friedman
Update on the effect of exogenous hormone use on glioma risk in women: a meta-analysis of case-control and cohort studies
Yu-Long Lan, Xun Wang, Jia-Cheng Lou, Bin-Bin Ma, Jin-Shan Xing, Shuang Zou, Bo Zhang
Is a pretreatment radiological staging system feasible for suggesting the optimal extent of resection and predicting prognosis in glioblastoma? An observational study
Jaume Capellades, Josep Puig, Sira Domenech, Teresa Pujol, Laura Oleaga, Angels Camins, Carles Majós, Rocio Diaz, Christian de Quintana, Pilar Teixidor, Gerard Conesa, Gerard Plans, Josep Gonzalez, Natalia García-Balañà, Jose Maria Velarde, Carmen Balaña
To drive or not to drive, that is still the question: current challenges in driving recommendations for patients with brain tumours
Ann Mansur, Alexa Desimone, Sara Vaughan, Tom A. Schweizer, Sunit Das
Treatment and outcomes of 28 patients with spinal metastasis from gynecological cancer
Xin Gao, Chenglong Zhao, Shaohui He, Tianqi Fan, Wei Xu, Cheng Yang, Tielong Liu, Jianru Xiao
Transforming growth factor beta induced (TGFBI) is a potential signature gene for mesenchymal subtype high-grade glioma
Yuan-Bo Pan, Chi-Hao Zhang, Si-Qi Wang, Peng-Hui Ai, Kui Chen, Liang Zhu, Zhao-Liang Sun, Dong-Fu Feng
Outcomes after second surgery for recurrent glioblastoma: a retrospective case–control study
Alysson Wann, Patrick A. Tully, Elizabeth H. Barnes, Zarnie Lwin, Rosalind Jeffree, Katharine J. Drummond, Hui Gan, Mustafa Khasraw
Tumor microenvironment after biodegradable BCNU wafer implantation: special consideration of immune system
Ichiyo Shibahara, Mitsuto Hanihara, Takashi Watanabe, Mitsuru Dan, Sumito Sato, Hiroki Kuroda, Akinori Inamura, Madoka Inukai, Atsuko Hara, Yoshie Yasui, Toshihiro Kumabe
Clinical and dosimetric study of radiotherapy for glioblastoma: three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy
David Thibouw, Gilles Truc, Aurélie Bertaut, Cédric Chevalier, Léone Aubignac, Céline Mirjolet
Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients
J. N. Jakobsen, T. Urup, K. Grunnet, A. Toft, M. D. Johansen, S. H. Poulsen, I. J. Christensen, A. Muhic, H. S. Poulsen